High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer

Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis

(2013) Zhongsheng Peng et al.   BMC CANCER

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Purification, characterization and anticancer activity of a polysaccharide from Panax ginseng

(2012) Cong Li et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

A Novel Muscarinic Antagonist R2HBJJ Inhibits Non-Small Cell Lung Cancer Cell Growth and Arrests the Cell Cycle in G0/G1

(2012) Nan Hua et al.   PLoS One

The role of nuclear medicine in modern therapy of cancer

(2012) Gabriela Kramer-Marek et al.   TUMOR BIOLOGY

Acetylcholine Receptor Expression in Merkel Cell Carcinoma

(2009) Jeremy W Bowers et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Genetic Ablation of M3 Muscarinic Receptors Attenuates Murine Colon Epithelial Cell Proliferation and Neoplasia

(2008) J.-P. Raufman et al.   CANCER RESEARCH

Akt-dependent NF-κB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis

(2008) Jasleen Shant et al.   EXPERIMENTAL CELL RESEARCH

Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling

(2007) Jean-Pierre Raufman et al.   JOURNAL OF CELLULAR PHYSIOLOGY